Procter & Gamble (NYSE:PG) CEO Paul Gama Sells 2,894 Shares of Stock

Key Points

• CEO Paul Gama sold 2,894 Procter & Gamble shares at an average price of $165, generating $477,510; his direct holdings fell 6.18% to 43,899 shares. He also sold shares in two earlier October transactions.
• Procter & Gamble reported quarterly earnings of $2.00 per share, beating estimates by $0.11, while revenue rose 4% year over year to $23.28 billion. The company declared a quarterly dividend of $1.0885 per share, equivalent to a 2.7% yield.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $170.57, compared with the stock’s reported price of $161.97; institutional investors own 65.77% of PG shares.

Procter & Gamble Company (The) (NYSE:PG - Get Free Report) CEO Paul Gama sold 2,894 shares of the company's stock in a transaction dated Friday, October 30th. The stock was sold at an average price of $165.00, for a total transaction of $477,510.00. Following the completion of the sale, the chief executive officer directly owned 43,899 shares of the company's stock, valued at $7,243,335. The trade was a 6.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Paul Gama also recently made the following trade(s):

• On Friday, October 23rd, Paul Gama sold 4,331 shares of Procter & Gamble stock. The stock was sold at an average price of $161.27, for a total transaction of $698,460.37.
• On Monday, October 5th, Paul Gama sold 2,225 shares of Procter & Gamble stock. The stock was sold at an average price of $145.34, for a total transaction of $323,381.50.

Procter & Gamble Stock Performance

Shares of NYSE PG traded down $1.59 during midday trading on Tuesday, reaching $161.97. The company's stock had a trading volume of 1,555,851 shares, compared to its average volume of 9,691,114. The stock has a market capitalization of $375.40 billion, a P/E ratio of 24.38, a PEG ratio of 3.89 and a beta of 0.39. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. The firm has a 50 day moving average price of $150.37 and a 200-day moving average price of $149.04. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts' consensus estimates of $1.89 by $0.11. The company had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. Procter & Gamble's revenue was up 4.0% on a year-over-year basis. During the same period last year, the business posted $1.99 earnings per share. As a group, equities analysts predict that Procter & Gamble Company will post 6.99 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. Procter & Gamble's dividend payout ratio (DPR) is currently 65.51%.

Analysts Set New Price Targets

PG has been the topic of a number of recent analyst reports. Sanford C. Bernstein reissued a "market perform" rating and issued a $149.00 price target on shares of Procter & Gamble in a report on Monday, August 24th. TD Cowen increased their price target on shares of Procter & Gamble from $150.00 to $166.00 and gave the company a "hold" rating in a research report on Friday, October 23rd. Barclays raised their price objective on shares of Procter & Gamble from $152.00 to $165.00 and gave the stock an "equal weight" rating in a report on Monday, October 26th. Royal Bank Of Canada set a $169.00 price objective on shares of Procter & Gamble in a research report on Friday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Procter & Gamble in a research note on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of "Moderate Buy" and a consensus target price of $170.57.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in PG. BlackRock Inc. bought a new position in Procter & Gamble in the 2nd quarter worth approximately $27,862,105,000. Bank of America Corp DE purchased a new position in Procter & Gamble in the 2nd quarter valued at approximately $3,850,628,000. Bank of New York Mellon Corp bought a new stake in Procter & Gamble during the 2nd quarter valued at $2,281,505,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Procter & Gamble during the 2nd quarter valued at $1,480,650,000. Finally, Corient Private Wealth LP purchased a new stake in shares of Procter & Gamble during the second quarter worth $335,908,000. Institutional investors own 65.77% of the company's stock.

Procter & Gamble Company Profile

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.